Proteomics and autoimmune kidney disease

Clinical Immunology

Volumn 161, Issue 1, 2015, Pages 23-30

  Rovin, Brad H ^a   Klein, Jon B ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Proteomics

Indexed keywords

ANGIOSTATIN; AUTOANTIBODY; BIOLOGICAL MARKER; CREATININE; IMMUNOGLOBULIN; PHOSPHOLIPASE A2 RECEPTOR; PROTEIN; PROTEOME; TAMM HORSFALL GLYCOPROTEIN; THROMBOSPONDIN; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANGIOGENESIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC KIDNEY DISEASE; DENSITY GRADIENT CENTRIFUGATION; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS CAPILLARY; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; LUPUS ERYTHEMATOSUS NEPHRITIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TREATMENT RESPONSE; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRAFILTRATION; AUTOIMMUNE DISEASES; CLASSIFICATION; KIDNEY DISEASES; METABOLISM; SENSITIVITY AND SPECIFICITY; URINE;

AUTOIMMUNE DISEASES; BIOMARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; KIDNEY DISEASES; PROTEOME; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84949533614     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.04.021     Document Type: Article

References (27)

1. Thongboonkerd V., McLeish K.R., Arthur J.M., Klein J.B. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002, 62(4):1461-1469.
2. Shen Y., Zhao R., Berger S.J., Anderson G.A., Rodriguez N., Smith R.D. High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal. Chem. 2002, 74(16):4235-4249.
3. Cutillas P.R., Norden A.G., Cramer R., Burlingame A.L., Unwin R.J. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin. Sci. (Lond). 2003, 104(5):483-490.
4. Adachi J., Kumar C., Zhang Y., Olsen J.V., Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7(9):R80.
5. Michalski A., Damoc E., Lange O., Denisov E., Nolting D., Muller M., et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 2012, 11(3). (O111 013698).
6. Santucci L., Candiano G., Petretto A., Bruschi M., Lavarello C., Inglese E., et al. From hundreds to thousands: Widening the normal human Urinome (1). J. Proteomics 2015, 112:53-62.
7. Thongboonkerd V., Klein J.B., Arthur J.M. Proteomic identification of a large complement of rat urinary proteins. Nephron. Exp. Nephrol. 2003, 95(2):e69-e78.
8. Kullolli M., Warren J., Arampatzidou M., Pitteri S.J. Performance evaluation of affinity ligands for depletion of abundant plasma proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 939:10-16.
9. Merchant M.L., Niewczas M.A., Ficociello L.H., Lukenbill J.A., Wilkey D.W., Li M., et al. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int. 2013, 83(6):1177-1184.
10. Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(36):13368-13373.
11. Hsieh C., Chang A., Brandt D., Guttikonda R., Utset T.O., Clark M.R. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 2011, 63(6):865-874.
12. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., et al. Laser capture microdissection. Science 1996, 274(5289):998-1001.
13. Satoskar A.A., Shapiro J.P., Bott C.N., Song H., Nadasdy G.M., Brodsky S.V., et al. Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli. Mod. Pathol. 2012, 25(5):709-721.
14. Shapiro J.P., Biwas S., Merchant A.S., Satoskar A., Taslim C., Lin S., et al. A quantitative proteomic workflow for characterization of frozen clinical biopsies: Laser capture microdissection coupled with label-free mass spectrometry. J. Proteomics 2012, 77:433-440.
15. Sethi S., Vrana J.A., Theis J.D., Dogan A. Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr. Opin. Nephrol. Hypertens. 2013, 22(3):273-280.
16. Jain D., Green J.A., Bastacky S., Theis J.D., Sethi S. Membranoproliferative glomerulonephritis: the role for laser microdissection and mass spectrometry. Am. J. Kidney Dis. 2014, 63(2):324-328.
17. Regent A., Lofek S., Dib H., Bussone G., Tamas N., Federici C., et al. Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach. Clin. Immunol. 2014, 153(1):123-135.
18. Beck L.H., Bonegio R.G.B., Lambeau G., Beck D.M., Powell D.W., Cummins T.D., et al. M-type phospholipase A(sub 2) receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 2009, 361(1):11-21.
19. Tomas N.M., Beck L.H., Meyer-Schwesinger C., Seitz-Polski B., Ma H., Zahner G., et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med. 2014, 371(24):2277-2287.
20. Bruschi M., Sinico R.A., Moroni G., Pratesi F., Migliorini P., Galetti M., et al. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: alpha-enolase and annexin AI. J. Am. Soc. Nephrol. 2014, 25(11):2483-2498.
21. Kikuchi T., Yoshida Y., Morioka T., Gejyo F., Oite T. Human voltage-dependent anion selective channel 1 is a target antigen for antiglomerular endothelial cell antibody in mixed connective tissue disease. Mod. Rheumatol. 2008, 18(6):570-577.
22. Haubitz M., Wittke S., Weissinger E.M., Walden M., Rupprecht H.D., Floege J., et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005, 67(6):2313-2320.
23. Varghese S.A., Powell T.B., Budisavljevic M.N., Oates J.C., Raymond J.R., Almeida J.S., et al. Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol. 2007, 18:913-922.
24. Zhang X., Jin M., Wu H., Nadasdy T., Nadasdy G., Harris N., et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 2008, 74(6):799-807.
25. Wu T., Du Y., Han J., Singh S., Xie C., Guo Y., et al. Urinary angiostatin-a novel putative marker of renal pathology chronicity in lupus nephritis. Mol. Cell. Proteomics 2013, 12(5):1170-1179.
26. Surin B., Sachon E., Rougier J.P., Steverlynck C., Garreau C., Lelongt B., et al. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy. Proteomics 2013, 13(1):142-152.
27. Gillet L.C., Navarro P., Tate S., Rost H., Selevsek N., Reiter L., et al. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell. Proteomics 2012, 11(6). (O111 016717).